AquaBounty

The underlying genetic technology that accelerates the growth and reduces the time to market for the AquAdvantage salmon was developed in 1989 at Memorial University in Newfoundland, Canada. In 2003, the first regulatory study of the fish was submitted in the U.S. to the Food and Drug Administration , who ruled that the fish were safe to eat and posed no threat to the environment when farmed in land-based aquaculture farms. In 2012, a submission was made to Health Canada to allow the sale of the genetically modified fish in Canada and the application was subsequently approved. AquAdvantage salmon received FDA approval in 2015 and the first U.S. harvest of salmon occurred in 2020 at their Indiana-located aquafarm. As of 2022, a production facility is in construction in Ohio.